RESMED INC

ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company designs innovative technology, including artificial intelligence (AI) powered digital health solutions, cloud-connected devices, and intelligent software, to make home healthcare more personalized, accessible, and effective. Its products aim to improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems. Formed in 1989, ResMed commercialized a continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA), which was the first successful non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a mask, to prevent upper airway collapse during sleep. The company has since expanded its business to include innovative products and solutions for a broad range of sleep and related breathing health disorders. These technologies are applied in medical and consumer products, life support and ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, and dental devices. ResMed is also a leading provider of cloud-based health applications, software, and devices for connected care. These solutions enable clinicians to manage more patients efficiently and effectively, and encourage patients' long-term adherence to and satisfaction with their therapy. In June 2026, ResMed acquired Noctrix Health, LLC, a company with an FDA De Novo classified medical device that treats restless legs syndrome. This acquisition expands ResMed's clinical sleep health portfolio into an adjacent area of unmet need, with Noctrix operating as a wholly owned subsidiary.